According to their observations, podoplanin positive CAFs predicted poor survival and outcome among lung adenocarcinoma and squamous cell carcinoma patients, whereas in small cell lung cancer podoplanin positivity suggested better prognosis [75]. The gene discussed is PDPN; the disease is small cell lung carcinoma.